Inscopix Launches $1 Million DECODE Grant Program For Neural Circuit-Level Investigation of Brain Disease
PALO ALTO, Calif., June 16, 2014 /PRNewswire/ -- Inscopix, Inc. ("Inscopix") today announced the launch of its DECODE (Deciphering Circuit Basis of Disease) Grant Program in response to President Obama's "all hands on deck" call to action for the BRAIN Initiative. Through the $ 1 Million DECODE Grant Program, Inscopix hopes to bolster extramural research efforts for investigating how aberrant neural circuit activity contributes to brain malfunction in a diverse range of neurological and psychiatric disorders. Inscopix CEO Dr. Kunal Ghosh, noted, "What Inscopix does is really the essence of the BRAIN Initiative, which is to understand how patterns of electrical and chemical activity flowing through specific brain circuits give rise to cognition and behavior ." "We believe that by leveling the playing field through technology dissemination and training, Inscopix can truly make a unique and high-impact contribution to understanding the circuit basis of brain disorders," said Ghosh.
Inscopix's DECODE competitive grant application process will be open to Principal Investigators or Group Leaders at any Public or Private research organization. An all-star panel of neuroscientists and brain-disease experts will select between three to five meritorious proposals that will receive the two-year in-kind award comprising Inscopix's nVista HD imaging systems, and access to its robust scientific and intellectual infrastructure. Through this grant, Inscopix aims to identify and support neuroscience researchers who push the envelope, fostering new avenues of thought and shifting paradigms in how brain dysfunctions are studied and treated.
Applications are due September 15, 2014. For more information or to apply, visit www.inscopix.com/grants
About Inscopix, Inc.
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the means to relate neural circuit dynamics to corresponding behavior. With its flagship product, nVista HD, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data sets and make breakthrough scientific discoveries. With in-house neuroscience expertise combined with strategic collaborations around the world, Inscopix stands at the brink of making fundamental advances in basic brain research and treatments for diseases such as Parkinson's, autism and schizophrenia.
SOURCE Inscopix, Inc.